scispace - formally typeset
J

Jerry S.H. Lee

Researcher at University of Southern California

Publications -  61
Citations -  5607

Jerry S.H. Lee is an academic researcher from University of Southern California. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 22, co-authored 53 publications receiving 4866 citations. Previous affiliations of Jerry S.H. Lee include Uniformed Services University of the Health Sciences & National Institutes of Health.

Papers
More filters
Posted Content

A field guide to cultivating computational biology.

TL;DR: In this paper, the authors propose solutions for individual scientists, institutions, journal publishers, funding agencies, and educators to advance career advancement, publication, and grant review in biomedical research.

Detection and visualization of HER2 clustering using an Aggregation Induced Emission based fluorescent probe molecule

TL;DR: In this article , the authors proposed and demonstrated a new fluorophore for imaging HER2 clustering behavior based on the organic molecule Tetraphenylethylene (TPE), which undergoes aggregation induced emission (AIE), a unique photophysical behaviour that results in an increase in fluorescent signal when the molecular motion of the TPE-containing molecule is restricted.
Journal ArticleDOI

Changing epidemiology of esophageal cancer: A population-based study over 43 years (1975–2018).

TL;DR: The AAIR of EC as a whole has been decreasing since 2004, and the incidence of ACE has, for the first time, plateaued in the most recent decade (2006-2018), after having risen for three preceding decades (1975-2006).
Journal ArticleDOI

Chemotherapy Treatment Costs and Clinical Outcomes of Colon Cancer in the U.S. Military Health System's Direct and Private Sector Care Settings.

TL;DR: In this article , the authors studied the relationship between chemotherapy treatment and the cost paid by the Department of Defense (DoD) for treatment in relation to clinical outcomes among patients with colon cancer treated within the U.S. Military Health System's direct and private sector care settings to better understand the value of cancer care.